The Radiation Research Centre of Excellence (RadNet-CoE) at The Institute of Cancer Research and The Royal Marsden brings together preeminent leaders in radiotherapy, immunotherapy, cancer biology, ...

The trial expansion was granted after RevBio demonstrated the safety of Tetranite in the first five treated patients.

As a result of the preliminary STOMP data – which gave the chances of a positive outcome from the study at less than 1% – the ...

Scientists comment on new legislation on regulatory frameworks for clinical trials, as laid out by UK Parliament. Dr Catriona Manville, Director of Research Policy at the Association of Medical ...

Keros will host an update call and webcast today, December 12, 2024, at 8:00 a.m. ET LEXINGTON, Mass., Dec. 12, 2024 (GLOBE ...

Stoke Therapeutics is nearing FDA sign-off on a groundbreaking Phase 3 clinical trial for its experimental drug for Dravet ...